MRI role #PCascreening Current evidence by @mrsprostate - less frequent biopsy - more csPCa diagnosed - less ciPCa - systematic biopsy not needed #eau26

Tumor markers in #PCascreening Take home message: screen all men in mid life, use secondary screening tests prior to prostate biopsy (markers have better NPV compared to MRI) @dr_coops #eau26

Fascinating on UK #PCaScreening •Men 50-69 yo ❌️ (n=8.2M) •Familial risk ❌️ (1M) •Black ethnicity ❌️ (0.37M) •BRCA mutated ✅️ (21k) So...the screening gates opened for 1st time! 💥 Thoughtful from #NSC (but suspect many will be disappointed) bbc.co.uk/news/live/clykgr94…

Major updates from @Uroweb 2024 on prostate cancer screening and diagnosis trials - @nataliagandur #EAU24 #ClinicalTrials #CancerResearch #OncoDaily #Oncology #ProstateCancer #PSA #PCaScreening oncodaily.com/46057.html

💫🌟🔬 Major updates from #EAU24 on prostate cancer (PCa) screening & diagnosis trials! 🚀🌟💫 @OncoAlert @APCCC_Lugano @Silke_Gillessen eaucongress.uroweb.org/game-… 1️⃣ PRIME Study shows biparametric MRI equals multiparametric MRI in detecting significant PCa, suggesting a new standard of care that's accessible & cost-effective.   2️⃣ PROBASE Trial challenges current guidelines, suggesting starting risk-adapted screening at age 45 could significantly reduce PCa risk without immediate follow-up for PSA<1.5 ng/ml.   3️⃣ ProScreen Trial finds combining PSA, kallikrein panel, & MRI improves detection of high-grade PCa, indicating a better balance of benefits & harms compared to PSA screening alone. 📊 These findings could revolutionize PCa screening, making it more effective & accessible! 🔗 For full insights, visit the EAU24 Resource Centre. #ProstateCancer #MedicalResearch #PCaScreening

📣 Exciting News! Save the date for our upcoming webinar! Join us on Friday, March 22, 11am EDT / 3pm GMT (UK) / 4pm CET, as we delve into the latest in #PCaScreening and clinical research. Discover the crucial role of #AI in shaping patient-centered screening pathways. 👉 Registration is open! Secure your spot now: bit.ly/3Pf4gv0

Trials show that #PCaScreening led to a 44% decrease in death due to prostate cancer, but still anti-PSA propaganda is being circulated. Now we are able to avoid over-diagnosis. The EU must extend support for #earlydetection with PSA testing and risk calculators before biopsy.